MARKET NEWS

Atossa Therapeutics Announces Preliminary Results from Phase 1 Clinical Study of Nasal Spray Being Developed for COVID-19
IntelGenx Announces Issuance of US Patent for Novel Technology Applicable to Cannabis-Containing Oral Films
XOMA Earns First Milestone Payment From 2018 Royalty Purchase Agreement
Halberd Corporation Files for Patent Protection on Enhanced Nasal Spray to Prevent Covid-19
Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID its Single-Dose Intranasal Vaccine Candidate for COVID-19
4D Pharma Presents New Data From Two MRx0518 Clinical Trials 

  FEATURED EDITORIAL

  COMPANY PROFILE

Established in 1949, Stevanato Group is the world’s largest, privately owned designer and producer of glass containers for the pharmaceutical industry. From its outset, the Group has developed its own glass-converting technology to ensure the highest standards of quality. The Group comprises a wide set of capabilities dedicated to serving the biopharmaceutical and diagnostic industries: from glass containers with its historical brand Ompi, to high-precision plastic diagnostic and medical components, to contract manufacturing for drug delivery devices, to vision inspection systems, assembly, and packaging equipment. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Benefits of Small-Scale Drug Development

Benefits of Small-Scale Drug Development

Kieran Coffey, Technical Lead at Pfizer CentreOne’s Newbridge facility, discusses the benefits of small-scale processing for process development of tablet products.

Croda Enters Contract With Pfizer for Innovative Delivery System for COVID-19 Vaccine

Croda Enters Contract With Pfizer for Innovative Delivery System for COVID-19 Vaccine

Croda International Plc recently announced it has entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19….

Axovant Gene Therapies Announces FDA Clearance of IND for Gene Therapy 

Axovant Gene Therapies Announces FDA Clearance of IND for Gene Therapy 

Axovant Gene Therapies Ltd. recently announced the US FDA has lifted its clinical hold and cleared the Investigational New Drug (IND) Application to initiate a registrational study of….

Mateon Therapeutics & Windlas Biotech Enter Commercialization Agreement for Covid-19 Drug

Mateon Therapeutics & Windlas Biotech Enter Commercialization Agreement for Covid-19 Drug

Mateon Therapeutics recently announced an agreement with Windlas Biotech Pvt. Ltd. of India (Windlas) to commercialize ARTIVeda, Mateon’s lead ethnobiology….

Dolomite Microfluidics & MilliporeSigma Collaborate to Release Off-the-Shelf Microfluidic Device Kits for the Fabrication of PLGA Particles

Dolomite Microfluidics & MilliporeSigma Collaborate to Release Off-the-Shelf Microfluidic Device Kits for the Fabrication of PLGA Particles

Dolomite Microfluidics and MilliporeSigma have partnered to create a range of off-the-shelf NanoFabTx™ microfluidic device kits for the production of….

Pfizer & BioNTech Reach Agreement to Supply the EU With 200 Million Doses of COVID-19 Vaccine

Pfizer & BioNTech Reach Agreement to Supply the EU With 200 Million Doses of COVID-19 Vaccine

Pfizer and BioNTech SE recently announced they have reached an agreement with the European Commission to supply 200 million doses of their investigational….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

November 25 – Analytical Instruments
December 2 – Formulation Development